Restricted accessResearch articleFirst published online 2014-10
A Monoclonal Antibody Against the Extracellular Domain of Mouse and Human Epithelial V-like Antigen 1 Reveals a Restricted Expression Pattern Among CD4- CD8- Thymocytes
Expression of transcripts for the homotypic adhesion protein epithelial V-like antigen 1 (EVA1), also known as myelin protein zero like-2 (Mpzl2), is known to be present in thymic stromal cells. However, protein expression within different thymic subsets, stromal and/or lymphoid, has not been characterized due a lack of specific reagents. To address this, we generated a hybridoma (G9P3-1) secreting a monoclonal antibody (G9P3-1Mab), reactive against both human and mouse EVA1. The G9P3-1Mab was generated by immunizing Mpzl2-deficient gene-targeted mice with the extracellular domain of EVA1, followed by a conventional hybridoma fusion protocol, illustrating the feasibility of using gene-targeted mice to generate monoclonal antibodies with multiple species cross-reactivity. We confirmed expression of EVA1 on cortical and medullary epithelial cell subsets and revealed a restricted pattern of expression on CD4- CD8- double negative (DN) cell subsets, with the highest level of expression on DN3 (CD44lowCD25+) thymocytes. G9P3-1MAb is a valuable reagent to study thymic T cell development and is likely useful for the analysis of pathological conditions affecting thymopoiesis, such as thymic involution caused by stress or aging.
Get full access to this article
View all access options for this article.
References
1.
GodfreyDI, KennedyJ, SudaT, and ZlotnikA: A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol, 1993; 150:4244–4252.
2.
AlvesNL, HuntingtonND, RodewaldHR, and Di SantoJP: Thymic epithelial cells: the multi-tasking framework of the T cell “cradle.”. Trends Immunol, 2009; 30:468–474.
3.
PetrieHT, and Zuniga-PfluckerJC: Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu Rev Immunol, 2007; 25:649–679.
4.
TakahamaY: Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol, 2006; 6:127–135.
5.
PorrittHE, GordonK, and PetrieHT: Kinetics of steady-state differentiation and mapping of intrathymic-signaling environments by stem cell transplantation in nonirradiated mice. J Exp Med, 2003; 198:957–962.
6.
LindEF, ProckopSE, PorrittHE, and PetrieHT: Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development. J Exp Med, 2001; 194:127–134.
7.
HaraT, ShitaraS, ImaiK, MiyachiH, KitanoS, YaoH, Tani-IchiS, and IkutaK: Identification of IL-7-producing cells in primary and secondary lymphoid organs using IL-7-GFP knock-in mice. J Immunol, 2012; 189:1577–1584.
8.
MohtashamiM, and Zuniga-PfluckerJC: Three-dimensional architecture of the thymus is required to maintain delta-like expression necessary for inducing T cell development. J Immunol, 2006; 176:730–734.
9.
van EwijkW, HollanderG, TerhorstC, and WangB: Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. Development, 2000; 127:1583–1591.
10.
LeeHW, ParkHK, NaYJ, KimCD, LeeJH, KimBS, KimJB, LeeCW, MoonJO, and YoonS: RANKL stimulates proliferation, adhesion and IL-7 expression of thymic epithelial cells. Exp Mol Med, 2008; 40:59–70.
11.
HikosakaY, NittaT, OhigashiI, YanoK, IshimaruN, HayashiY, MatsumotoM, MatsuoK, PenningerJM, TakayanagiH, YokotaY, YamadaH, YoshikaiY, InoueJ, AkiyamaT, and TakahamaY: The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. Immunity, 2008; 29:438–450.
12.
AwongG, SinghJ, MohtashamiM, MalmM, La Motte-MohsRN, BenvenistePM, SerraP, HererE, van den BrinkMR, and Zuniga-PfluckerJC: Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture. Blood, 2013; 122:4210–4219.
13.
AndersonG, and JenkinsonEJ: Lymphostromal interactions in thymic development and function. Nat Rev Immunol, 2001; 131–140.
14.
St-PierreY, HugoP, LegaultD, TremblayP, and PotworowskiEF: Modulation of integrin-mediated intercellular adhesion during the interaction of thymocytes with stromal cells expressing VLA-4 and LFA-1 ligands. Eur J Immunol, 1996; 26:2050–2055.
15.
SalomonDR, CrisaL, MojcikCF, IshiiJK, KlierG, and ShevachEM: Vascular cell adhesion molecule-1 is expressed by cortical thymic epithelial cells and mediates thymocyte adhesion. Implications for the function of alpha4beta1 (VLA4) integrin in T-cell development. Blood, 1997; 89:2461–2471.
16.
ProckopSE, PalenciaS, RyanCM, GordonK, GrayD, and PetrieHT: Stromal cells provide the matrix for migration of early lymphoid progenitors through the thymic cortex. J Immunol, 2002; 169:4354–4361.
17.
KishimotoH, CaiZ, BrunmarkA, JacksonMR, PetersonPA, and SprentJ: Differing roles for B7 and intercellular adhesion molecule-1 in negative selection of thymocytes. J Exp Med, 1996; 184:531–537.
18.
BushellKM, SollnerC, Schuster-BoecklerB, BatemanA, and WrightGJ: Large-scale screening for novel low-affinity extracellular protein interactions. Genome Res, 2008; 18:622–630.
19.
GuttingerM, SuttiF, PanigadaM, PorcelliniS, MeratiB, MarianiM, TeesaluT, ConsalezGG, and GrassiF: Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis. J Cell Biol, 1998; 141:1061–1071.
20.
TeesaluT, GrassiF, and GuttingerM: Expression pattern of the epithelial v-like antigen (Eva) transcript suggests a possible role in placental morphogenesis. Dev Genet, 1998; 23:317–323.
21.
IacovelliS, IosueI, Di CesareS, and GuttingerM: Lymphoid EVA1 expression is required for DN1-DN3 thymocytes transition. PLoS One, 2009; 4:e7586.
22.
TydellCC, David-FungES, MooreJE, RowenL, TaghonT, and RothenbergEV: Molecular dissection of prethymic progenitor entry into the T lymphocyte developmental pathway. J Immunol, 2007; 179:421–438.
23.
GriffithAV, FallahiM, NakaseH, GosinkM, YoungB, and PetrieHT: Spatial mapping of thymic stromal microenvironments reveals unique features influencing T lymphoid differentiation. Immunity, 2009; 31:999–1009.
24.
DemonteL, PorcelliniS, TafiE, SheridanJ, GordonJ, DepreterM, BlairN, PanigadaM, SanvitoF, MeratiB, AlbientzA, BarthlottT, OzmenL, BlackburnCC, and GuttingerM: EVA regulates thymic stromal organisation and early thymocyte development. Biochem Biophys Res Commun, 2007; 356:334–340
25.
YokoyamaWM, ChristensenM, SantosGD, and MillerD: Production of monoclonal antibodies. Curr Protoc Immunol, 2006; Ch2:Unit25.
26.
SeachN, WongK, HammettM, BoydRL, and ChidgeyAP: Purified enzymes improve isolation and characterization of the adult thymic epithelium. J Immunol Methods, 2012; 85:23–34.
27.
TeagueTK, TanC, MarinoJH, DavisBK, TaylorAA, HueyRW, and Van De WieleCJ: CD28 expression redefines thymocyte development during the pre-T to DP transition. Int Immunol, 2010; 22:387–397.
28.
AwD, SilvaAB, MaddickM, von ZglinickiT, and PalmerDB: Architectural changes in the thymus of aging mice. Aging Cell, 2008; 7:158–167.
29.
FineJS, and KruisbeekAM: The role of LFA-1/ICAM-1 interactions during murine T lymphocyte development. J Immunol, 1991; 147:2852–2859.
30.
NakataH, WakayamaT, AdthapanyawanichK, NishiuchiT, MurakamiY, TakaiY, and IsekiS: Compensatory upregulation of myelin protein zero-like 2 expression in spermatogenic cells in cell adhesion molecule-1-deficient mice. Acta Histochem Cytochem, 2012; 45:47–56.
31.
PalmerDB: The effect of age on thymic function. Front Immunol, 2013; 4:316.
32.
LivakKJ, and SchmittgenTD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 2001; 25:402–408.
